EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Down 38.5% in July

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a significant decrease in short interest in July. As of July 15th, there was short interest totaling 24,493 shares, a decrease of 38.5% from the June 30th total of 39,841 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 180,734 shares, the days-to-cover ratio is presently 0.1 days.

EssilorLuxottica Stock Up 0.1%

Shares of ESLOY traded up $0.07 during trading hours on Friday, hitting $94.67. 302,471 shares of the company were exchanged, compared to its average volume of 124,970. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99. The firm’s 50 day moving average is $98.41 and its 200-day moving average is $117.32. EssilorLuxottica has a 52 week low of $91.44 and a 52 week high of $186.81.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ESLOY shares. Deutsche Bank Aktiengesellschaft began coverage on shares of EssilorLuxottica in a research note on Tuesday, May 12th. They issued a “hold” rating on the stock. The Goldman Sachs Group downgraded shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Finally, Zacks Research lowered EssilorLuxottica from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 23rd. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.